News FDA cracks down on bogus cell therapy firms The FDA’s commissioner Scott Gottlieb has pledged to crack down on “unscrupulous actors” attempting to treat patients with potentially dangerous or unproven stem cell therapies.
News FDA names MDMA a 'breakthrough' for post-traumatic stress US non-profit organisation to begin late-stage trials this year
News FDA and EMA reach milestone in sharing confidential informat... New agreement is culmination of three years of work by FDA and EMA
News US opioid crisis a 'national emergency', says Trump Declaration means potential more resources and power to states and federal agencies.
News Vernalis shares slide after latest FDA rejection Shares in UK pharma Vernalis slid more than 15% after the US regulator rejected its cough and cold treatment, known as CCP-08.
News AZ immunotherapy gets FDA boost in early lung cancer Imfinzi given Breakthrough Therapy designation from the FDA.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.